LOTEPREDNOL ETABONATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for loteprednol etabonate and what is the scope of freedom to operate?
Loteprednol etabonate
is the generic ingredient in seven branded drugs marketed by Bausch And Lomb Inc, Hikma, Sentiss, Sun Pharm, Bausch And Lomb, Alcon Labs Inc, Pharmos, Lupin Ltd, and Padagis Us, and is included in eighteen NDAs. There are twenty-one patents protecting this compound. Additional information is available in the individual branded drug profile pages.Loteprednol etabonate has one hundred and fourteen patent family members in sixteen countries.
There are ten drug master file entries for loteprednol etabonate. Eight suppliers are listed for this compound.
Summary for LOTEPREDNOL ETABONATE
International Patents: | 114 |
US Patents: | 21 |
Tradenames: | 7 |
Applicants: | 9 |
NDAs: | 18 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Clinical Trials: | 47 |
Patent Applications: | 5,966 |
Drug Prices: | Drug price trends for LOTEPREDNOL ETABONATE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for LOTEPREDNOL ETABONATE |
What excipients (inactive ingredients) are in LOTEPREDNOL ETABONATE? | LOTEPREDNOL ETABONATE excipients list |
DailyMed Link: | LOTEPREDNOL ETABONATE at DailyMed |
Recent Clinical Trials for LOTEPREDNOL ETABONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Price Vision Group | Phase 4 |
Kala Pharmaceuticals, Inc. | Phase 4 |
Thomas Chester, OD | Phase 4 |
Pharmacology for LOTEPREDNOL ETABONATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for LOTEPREDNOL ETABONATE
Anatomical Therapeutic Chemical (ATC) Classes for LOTEPREDNOL ETABONATE
Paragraph IV (Patent) Challenges for LOTEPREDNOL ETABONATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LOTEMAX SM | Ophthalmic Gel | loteprednol etabonate | 0.38% | 208219 | 1 | 2022-11-14 |
US Patents and Regulatory Information for LOTEPREDNOL ETABONATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch And Lomb | ZYLET | loteprednol etabonate; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050804-001 | Dec 14, 2004 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch And Lomb | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020583-001 | Mar 9, 1998 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOTEPREDNOL ETABONATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch And Lomb Inc | LOTEMAX | loteprednol etabonate | GEL;OPHTHALMIC | 202872-001 | Sep 28, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Bausch And Lomb | ALREX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020803-001 | Mar 9, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Bausch And Lomb | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020583-001 | Mar 9, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Pharmos | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020841-001 | Mar 9, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOTEPREDNOL ETABONATE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 1208161 | 顯示提高的粘膜轉移的藥物納米粒子 (PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT) | ⤷ Sign Up |
Chile | 2019003433 | ⤷ Sign Up | |
Chile | 2014002956 | Composicion farmaceutica ocular que comprende particulas recubiertas de dimension menor a 1 micron, con un nucleo que comprende etaboato de loteprednol y un recubrimiento con modificadores de superficie; y uso para tratar la inflamacion, degeneracion macular, edema macular u otro trastorno del ojo. | ⤷ Sign Up |
Brazil | 112014027296 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.